Protagonist Therapeutics (PTGX) Non-Current Deffered Revenue (2017 - 2025)
Protagonist Therapeutics' (PTGX) quarterly Non-Current Deffered Revenue came in at $2.8 million in Q3 2025, down 83.11% year-on-year from $16.5 million in Q3 2024, and down 48.13% quarter-over-quarter from $5.4 million in Q2 2025.
Protagonist Therapeutics (PTGX) Non-Current Deffered Revenue (2017 - 2025) Analysis & Trends
Protagonist Therapeutics has disclosed Non-Current Deffered Revenue across 6 years of filings, most recently posting $2.8 million for Q3 2025.
- Non-Current Deffered Revenue for Q3 2025 came in at $2.8 million, down 83.11% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.8 million (down 83.11% YoY), and the FY2024 annual result was $11.7 million, changed N/A from the prior year.
- Non-Current Deffered Revenue came in at $2.8 million for Q3 2025 at Protagonist Therapeutics, down from $5.4 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $28.9 million in Q1 2024 to a low of $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Protagonist Therapeutics | 7.35 Bn | 7.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 5.38 Mn |
| Mar 31, 2025 | 8.18 Mn |
| Dec 31, 2024 | 11.68 Mn |
| Sep 30, 2024 | 16.51 Mn |
| Jun 30, 2024 | 20.76 Mn |
| Mar 31, 2024 | 28.92 Mn |
| Sep 30, 2020 | 4.11 Mn |
| Jun 30, 2020 | 16.78 Mn |
| Mar 31, 2020 | 20.42 Mn |
| Dec 31, 2019 | 23.79 Mn |
| Sep 30, 2019 | 22.20 Mn |
| Jun 30, 2019 | 23.85 Mn |
| Dec 31, 2018 | 799,000.00 |
| Sep 30, 2018 | 797,000.00 |
| Jun 30, 2018 | 793,000.00 |
| Mar 31, 2018 | 694,000.00 |
| Dec 31, 2017 | 547,000.00 |
| Sep 30, 2017 | 332,000.00 |
| Jun 30, 2017 | 83,000.00 |